Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02521051
Title Phase I/II Trial of Alectinib and Bevacizumab in Patients With Advanced, Anaplastic Lymphoma Kinase (ALK)-Positive, Non-Small Cell Lung Cancer
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Massachusetts General Hospital
Indications

lung non-small cell carcinoma

Therapies

Bevacizumab

Alectinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Massachusetts General Hospital Recruiting Boston Massachusetts 02115 United States Details
Beth Israel Deaconess Medical Center Recruiting Boston Massachusetts 02155 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field